Ocuphire Pharma Inc
Biotechnology
Healthcare
OCUP
20.96 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
3.04
52 week high
6.38
high
3.17
52 week low
2.51
low
3.00
growth
-16.58 %
previous Close
3.01
P/E ratio
market cap
88.31 M
div yield
0
usd
Jun 2023
qoq
revenue
3.67 M
110.06 %
net incoming
-4.96 M
8.99 %
eps
0.00 %
14.29 %
eps surprise
-4.35 %
net profit margin
-135.03 %
176.00 %
operating incoming
-5.39 M
12.10 %
net change in cash
445 K
112.21 %
cash on hand
39.98 M
2.54 %
cost of revenue
0.00 %
top top